Cellular and animal models for diseases associated with altered mitochondrial function
CA 2326600 A1 · Owner: Clevenger, William · Inventors: Clevenger, William; Anderson, Christen M.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides methods for depleting mitochondrial DNA from insulin secreting cells using antiviral compounds and for producing , mitochondrial cytoplasmic hybrid ("cybrid") cells and animals from mitochondrial DNA depleted cells. Also provided are biological models for diseases associated with altered mitochondrial function including NIDDM, and , methods for diagnosis of such diseases and methods for screening agents useful for treating such diseases. Also provided are biological models and methods for evaluating an antiviral compound for its suitability for use in treating a virally-infected patient having a disease associated with impaired insulin secretion, and …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 28, 1999. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended April 28, 2019.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 28, 2021.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.